MGC Pharmaceuticals signs partnership to launch international medicinal cannabis research hub

MGC Pharmaceuticals Ltd (ASX:MXC) has signed a binding partnership agreement with the Royal Melbourne Institute of Technology (RMIT) and The Hebrew University of Jerusalem (HUJ) to form a joint international medical research hub for medicinal cannabis innovation and technologies.

As an extension to MGC’s existing collaboration with RMIT, the new research hub, to be known as CannaHub, is a collaborative centre between MGC, RMIT and HUJ and will be an international shared library of research, data and analytics on medicinal cannabis and its uses including future medical applications and treatments.

The agreement represents a landmark achievement for MGC. The formation of CannaHub is the first time RMIT or HUJ has partnered with a private company to form a research institute in this sector.

READ: MGC Pharmaceuticals rockets up 37% after reimbursement win for cannabis epilepsy therapeutic

CannaHub’s research projects will initially focus on three key areas

... read more at: https://www.proactiveinvestors.com.au/companies/news/209426/mgc-pharmaceuticals-signs-partnership-to-launch-international-medicinal-cannabis-research-hub-209426.html

by